• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Barriers and Facilitators of High-Efficiency Clinical Pathway Implementation in Community Hospitals.社区医院高效临床路径实施的障碍与促进因素
Hosp Pediatr. 2023 Oct 1;13(10):931-939. doi: 10.1542/hpeds.2023-007173.
2
Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.使用理论领域框架和能力、机会、动机和行为(COM-B)模型识别医院环境中减少苯二氮䓬类药物和镇静催眠药使用的障碍和促进因素:一项定性研究。
BMJ Open. 2023 Feb 22;13(2):e066234. doi: 10.1136/bmjopen-2022-066234.
3
Defining barriers and enablers for clinical pathway implementation in complex clinical settings.定义复杂临床环境下临床路径实施的障碍和促进因素。
Implement Sci. 2018 Nov 12;13(1):139. doi: 10.1186/s13012-018-0832-8.
4
Facilitators and barriers to the implementation of new critical care practices during COVID-19: a multicenter qualitative study using the Consolidated Framework for Implementation Research (CFIR).在 COVID-19 期间实施新的重症监护实践的促进因素和障碍:使用整合实施研究框架(CFIR)的多中心定性研究。
BMC Health Serv Res. 2023 Mar 20;23(1):272. doi: 10.1186/s12913-023-09209-w.
5
Barriers and facilitators to implementing treatment for opioid use disorder in community hospitals.社区医院实施阿片类药物使用障碍治疗的障碍和促进因素。
J Subst Use Addict Treat. 2024 Dec;167:209520. doi: 10.1016/j.josat.2024.209520. Epub 2024 Sep 10.
6
Implementing Pediatric Asthma Pathways in Community Hospitals: A National Qualitative Study.实施社区医院儿科哮喘路径:一项全国性定性研究。
J Hosp Med. 2020 Jan 1;15(1):35-41. doi: 10.12788/jhm.3296. Epub 2019 Sep 18.
7
Nursing Home Staff Perceptions of Barriers and Facilitators to Implementing a Quality Improvement Intervention.养老院工作人员对实施质量改进干预措施的障碍和促进因素的看法。
J Am Med Dir Assoc. 2019 Jul;20(7):810-815. doi: 10.1016/j.jamda.2019.01.139. Epub 2019 Mar 7.
8
Implementation of an Academic-to-Community Hospital Intensive Care Unit Quality Improvement Program. Qualitative Analysis of Multilevel Facilitators and Barriers.学术型医院向社区医院重症监护病房质量改进计划的实施。多层次促进因素和障碍的定性分析。
Ann Am Thorac Soc. 2019 Jul;16(7):877-885. doi: 10.1513/AnnalsATS.201810-735OC.
9
Barriers and facilitators to implementing imaging-based diagnostic artificial intelligence-assisted decision-making software in hospitals in China: a qualitative study using the updated Consolidated Framework for Implementation Research.在中国医院实施基于影像的诊断人工智能辅助决策软件的障碍和促进因素:使用更新的实施研究综合框架进行的定性研究。
BMJ Open. 2024 Sep 10;14(9):e084398. doi: 10.1136/bmjopen-2024-084398.
10
Barriers and enablers in the implementation of a quality improvement program for acute coronary syndromes in hospitals: a qualitative analysis using the consolidated framework for implementation research.医院实施急性冠状动脉综合征质量改进计划的障碍和促进因素:应用实施研究综合框架的定性分析。
Implement Sci. 2022 Jun 1;17(1):36. doi: 10.1186/s13012-022-01207-6.

引用本文的文献

1
Readiness of General Hospitals That Participate in Pediatric Quality Improvement Initiatives.参与儿科质量改进计划的综合医院的准备情况。
Hosp Pediatr. 2025 Mar 1;15(3):273-282. doi: 10.1542/hpeds.2024-007930.

本文引用的文献

1
"These Are Our Kids": Qualitative Interviews With Clinical Leaders in General Emergency Departments on Motivations, Processes, and Guidelines in Pediatric Sepsis Care."这些是我们的孩子":普通急诊科室临床负责人的定性访谈,内容关于小儿脓毒症护理的动机、流程和指南。
Ann Emerg Med. 2022 Oct;80(4):347-357. doi: 10.1016/j.annemergmed.2022.05.030. Epub 2022 Jul 13.
2
Fidelity evaluation of the dialogue around respiratory illness treatment (DART) program communication training.呼吸疾病治疗(DART)方案沟通培训的对话忠实度评估。
Patient Educ Couns. 2022 Jul;105(7):2611-2616. doi: 10.1016/j.pec.2022.03.011. Epub 2022 Mar 14.
3
Implementing Improvements: Opportunities to Integrate Quality Improvement and Implementation Science.实施改进:整合质量改进和实施科学的机会。
Hosp Pediatr. 2021 May;11(5):536-545. doi: 10.1542/hpeds.2020-002246.
4
Pathways for Improving Inpatient Pediatric Asthma Care (PIPA): A Multicenter, National Study.改善住院儿科哮喘护理途径(PIPA):一项多中心、全国性研究。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2019-3026. Epub 2020 May 6.
5
Implementing Pediatric Asthma Pathways in Community Hospitals: A National Qualitative Study.实施社区医院儿科哮喘路径:一项全国性定性研究。
J Hosp Med. 2020 Jan 1;15(1):35-41. doi: 10.12788/jhm.3296. Epub 2019 Sep 18.
6
Quality and Safety of Pediatric Inpatient Care in Community Hospitals: A Scoping Review.社区医院儿科住院医疗服务的质量和安全性:范围综述。
J Hosp Med. 2019 Nov 1;14(11):694-703. doi: 10.12788/jhm.3268. Epub 2019 Sep 18.
7
Aligning Inpatient Pediatric Research With Settings of Care: A Call to Action.使住院儿科研究与护理环境相匹配:行动呼吁。
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2018-2648.
8
Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia.儿童肺炎住院患者中金黄色葡萄球菌的流行情况及抗葡萄球菌治疗的应用。
J Hosp Med. 2018 Dec 1;13(12):848-852. doi: 10.12788/jhm.3093. Epub 2018 Oct 31.
9
Barriers and Facilitators to Asthma Care After Hospitalization as Reported by Caregivers, Health Providers, and School Nurses.照顾者、医疗服务提供者和学校护士报告的住院后哮喘护理的障碍与促进因素
Hosp Pediatr. 2018 Nov;8(11):706-717. doi: 10.1542/hpeds.2017-0182. Epub 2018 Oct 4.
10
Facilitators of interdepartmental quality improvement: a mixed-methods analysis of a collaborative to improve pediatric community-acquired pneumonia management.跨部门质量改进的促进因素:一项改善儿科社区获得性肺炎管理的合作的混合方法分析。
BMJ Qual Saf. 2019 Mar;28(3):215-222. doi: 10.1136/bmjqs-2018-008065. Epub 2018 Aug 12.

社区医院高效临床路径实施的障碍与促进因素

Barriers and Facilitators of High-Efficiency Clinical Pathway Implementation in Community Hospitals.

作者信息

Outram Simon M, Rooholamini Sahar N, Desai Mansi, Edwards Yeelen, Ja Clairissa, Morton Kayce, Vaughan Jordan H, Shaw Judith S, Gonzales Ralph, Kaiser Sunitha V

机构信息

Department of Pediatrics, University of California, San Francisco, California.

Department of Pediatrics, University of Washington, Seattle, Washington.

出版信息

Hosp Pediatr. 2023 Oct 1;13(10):931-939. doi: 10.1542/hpeds.2023-007173.

DOI:10.1542/hpeds.2023-007173
PMID:37697946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10520265/
Abstract

BACKGROUND

An intervention that involved simultaneously implementing clinical pathways for multiple conditions was tested at a tertiary children's hospital and it improved care quality. We are conducting a randomized trial to evaluate this multicondition pathway intervention in community hospitals. Our objectives in this qualitative study were to prospectively (1) identify implementation barriers and (2) map barriers to facilitators using an established implementation science framework.

METHODS

We recruited participants via site leaders from hospitals enrolled in the trial. We designed an interview guide using the Consolidated Framework for Implementation Research and conducted individual interviews. Analysis was done using constant comparative methods. Anticipated barriers were mapped to facilitators using the Capability, Opportunity, Motivation, Behavior Framework.

RESULTS

Participants from 12 hospitals across the United States were interviewed (n = 21). Major themes regarding the multicondition pathway intervention included clinician perceptions, potential benefits, anticipated barriers/challenges, potential facilitators, and necessary resources. We mapped barriers to additional facilitators using the Capability, Opportunity, Motivation, Behavior framework. To address limited time/bandwidth of clinicians, we will provide Maintenance of Certification credits. To address new staff and trainee turnover, we will provide easily accessible educational videos/resources. To address difficulties in changing practice across other hospital units, we will encourage emergency department engagement. To address parental concerns with deimplementation, we will provide guidance on parent counseling.

CONCLUSIONS

We identified several potential barriers and facilitators for implementation of a multicondition clinical pathway intervention in community hospitals. We also illustrate a prospective process for identifying implementation facilitators.

摘要

背景

在一家三级儿童医院对一项涉及同时为多种病症实施临床路径的干预措施进行了测试,结果显示该措施改善了护理质量。我们正在开展一项随机试验,以评估社区医院中这种多病症路径干预措施的效果。本定性研究的目的是前瞻性地:(1)识别实施障碍;(2)使用既定的实施科学框架将障碍映射到促进因素。

方法

我们通过参与试验的医院的现场负责人招募参与者。我们使用实施研究综合框架设计了一份访谈指南,并进行了个人访谈。分析采用持续比较法。使用能力、机会、动机、行为框架将预期障碍映射到促进因素。

结果

对来自美国12家医院的参与者进行了访谈(n = 21)。关于多病症路径干预措施的主要主题包括临床医生的看法、潜在益处、预期障碍/挑战、潜在促进因素和所需资源。我们使用能力、机会、动机、行为框架将障碍映射到其他促进因素。为解决临床医生时间/带宽有限的问题,我们将提供继续医学教育学分。为解决新员工和实习生流动的问题,我们将提供易于获取的教育视频/资源。为解决在其他医院科室改变实践的困难,我们将鼓励急诊科参与。为解决家长对取消实施的担忧,我们将提供家长咨询指导。

结论

我们确定了社区医院实施多病症临床路径干预措施的几个潜在障碍和促进因素。我们还展示了一个识别实施促进因素的前瞻性过程。